Emalex Biosciences received a patent covering an orally disintegrating tablet (ODT) formulation of ecopipam, an ...

The J. Reuben Long Detention Center has started a new initiative to enhance inmate communication, educational, and enrichment ...

Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA) has granted a five-year exemption from price ...

Enrolling Phase 2 DAYBreak CLL-201 bexobrutideg trial designed to support Accelerated Approval in relapsed/refractory chronic lymphocytic ...

Is your inbox overflowing with ads, newsletters, and social media updates? This one feature that's built into most email ...

Witness a heartwarming and creative transformation as an artist takes a broken device and turns it into a stunning piece of ...

Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) for Dapagliflozin Tablets, 5 mg and 10 mg (USRLD: Farxiga Tablets, 5 mg and 10 mg).

Thermo Fisher Scientific serves the pharmaceutical, biotech, and life sciences industries as a strategic contract development ...

Securus Technologies, an industry leader in corrections technology, is addressing this challenge by reimagining correctional facilities as secure, technology-enabled talent incubators, embedding ...

Drugmakers Novo Nordisk and Eli Lilly and Company have transformed the landscape of chronic weight loss management with the ...

Zydus Lifesciences rose 1.41% to Rs 885.95 after the company received final approval from the United States Food and Drug Administration (USFDA) for Dapagliflozin tablets, 5 mg and 10 mg.

World’s first dispersible tablets of Lasmiditan, designed to deliver rapid migraine relief by selectively targeting a ...